Unlock instant, AI-driven research and patent intelligence for your innovation.

Pharmaceutical compositions containing the extracts of Ilex latifolia as an active ingredient

A technology of holly vulgaris and active ingredients is applied in the directions of drug combinations, medical preparations containing active ingredients, functions of food ingredients, etc., which can solve the problems of unproven treatment effects of degenerative brain diseases, etc., and achieve the effect of inhibiting memory damage.

Inactive Publication Date: 2016-02-10
HANKOOK PHARM
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the therapeutic effect of Ilex japonicus on degenerative brain disorders has not actually been proven

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical compositions containing the extracts of Ilex latifolia as an active ingredient
  • Pharmaceutical compositions containing the extracts of Ilex latifolia as an active ingredient
  • Pharmaceutical compositions containing the extracts of Ilex latifolia as an active ingredient

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] The manufacture of embodiment 1 large-leaf holly (Ilexlatifolia) extract

[0052] Production of ethanol extract

[0053] Big-leaf holly is chopped and used after purchased at the Chinese herbal medicine market in Gyeongdong, Seoul. After preparing 100 g of Ilex japonica, it was extracted three times in a reflux condenser within three hours using 3 L of 100% ethanol at room temperature. The above solution was filtered through Waterman No. 1 paper and then dried to finally harvest 18.7 g of ethanol extract. The finally harvested holly extract is put into dimethyl sulfoxide (dimethylsulfoxide; DMSO) and dissolved into The concentration is stored at -20°C. During the experiment, the experiment buffer solution was diluted so that the final concentration of DMSO was less than 0.1% before use.

[0054] Manufacture of water extract

[0055] Except that water was used as the extraction medium instead of 100% ethanol, the powder (yield 21.5%) was obtained according to th...

Embodiment 2

[0060] Example 2 Induced cerebral infarction in rats, cerebral infarction and edema of Ilex japonicus extract Confirmation of inhibitory effect

[0061]The inventors of the present invention conducted the following experiment in order to confirm the efficacy of the extract of Ilex japonicus on rats with cerebral infarction. First, 300±5 g SD rats (SAMTAKO, Gyeonggi-do) were anesthetized by inhalation of 1-2% isoflurane (N2:O2=4:1), and the right carotid artery was carefully exposed surgically. In rats, the linguinal artery branching from the outer diameter artery to the central part and the thyroid artery (thyroid artery) branching from the external carotid artery to the inner carotid artery were ligated by electrocautery. At this time, 30 minutes before arterial ligation, one hour after ligation, and one hour after removal of the ligation, the extract of Ilex japonicus (50, 100, or 200 ㎎ / kg, respectively) or MK-801 (1 mg / kg) as a positive control group was fed. kg). Rat...

Embodiment 3

[0066] Embodiment 3 Passive avoidance test (passive avoidance test; Stepthrough) by rats and mice memory and learning

[0067] ICR mice (BioLinkCo. Korea) were used as experimental animals. After a period of adaptation period after purchase, they were fed with holly (25, 50 or 100 mg / kg) on ​​the first day of the experiment (day 0) and used 30 minutes later. 15 μl (15 nmol) of 1 mMAβ(25-35) (Bachem, Switzerland) was slowly injected into the ventricles of the brain with a microsyringe equipped with a 27-gauge nuddle (Maurice Tetal., Brain Research, 1996, 706: 181-193). Within one week thereafter, feed 25, 50 and 100 mg / kg of Ilex japonicus extract once a day respectively, and place the animals in open boxes step by step through the device (Stepthrough apparatus) (Gemini II avoidance system, Sandiego Instrument) Three open area applicable tests. On the 7th day, feed the Ilex japonicus extract (25, 50 or 100mg / kg), place the animal in the bright box after 30 minutes, open th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to compositions containing an active ingredient of Ilex latifolia extract for prevention or treatment of ischemic disease or degenerative brain disorders. Specifically, Ilex latifolia extract that is extracted with a solvent of water, alcohol or a mixture of water and alcohol is use shows suppression of brain infarction and edema in rats with induced cerebral infarction, and suppression of memory impairment in rats injected with amyloid [beta] protein (A [beta] (25-35)) to induce neurotoxicity, and confirms the ability of inhibiting oxidation reaction of hydrogen peroxide (H2O2)-induced, excitatory amino acids - glutamate, A [beta] (25-35)-induced neurotoxicity, and hypoxia-induced cell death of cerebral cortical neurons. Therefore, the Ilex extract according to the present invention can be used as pharmaceutical compositions for the prevention or treatment of ischemic disease or degenerative brain disorders, or as the active ingredient of healthy foods.

Description

technical field [0001] The present invention relates to a pharmaceutical composition for the prevention or treatment of ischemic disease or degenerative brain disease, and specifically, contains a plant extract as an active ingredient. Background technique [0002] The main cause of ischemic stroke (cerebralapoplexy), that is, cerebral infarction (cerebralinfarction) is cerebral artery thrombosis or embolism caused by vascular arteriosclerosis and cardiogenic embolism caused by heart disease and the like. Cerebral infarction caused by cerebrovascular blockage is further divided into cerebral thrombosis and cerebral embolism. Cerebral thrombosis is arteriosclerosis caused by high blood pressure, diabetes, and hyperlipidemia. The arterial wall becomes thicker or harder, resulting in narrowing of the blood vessel. The inner wall of the blood vessel is easily damaged and rough, and the blood flow is not smooth. Reduced or disrupted, brain cells are deprived of oxygen and nutrie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/185A61P9/10A61P25/28A61P25/14A61P25/00A23L33/105A23L33/00
CPCA23L33/105A23V2200/322A23V2250/21A61K36/185A61K2236/333A61P9/10A61P25/00
Inventor 成莲姬裴起焕刘载国金镇杓
Owner HANKOOK PHARM